1. Vitamin K2, a Naturally Occurring Menaquinone, Exerts Therapeutic Effects on Both Hormone-Dependent and Hormone-Independent Prostate Cancer Cells
   Abhilash Samykutty et al, 2013, Evidence-Based Complementary and Alternative Medicine CrossRef
2. High mobility group box 1 in diabetic nephropathy
   Haitao Shi et al, 2017 CrossRef
3. Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma.
   Wei Wang et al, 2013, Oncol Lett CrossRef
4. The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer.
   Kerrilyn R Diener et al, 2013, Immunol Cell Biol CrossRef
5. Potential markers for early diagnostics of Colorectal cancer and Inflammatory bowel disease in humans : intestinal microorganisms and immune system (teammates or rivals)
   Pavel Horak et al, 2017, Can J Biotech CrossRef
6. Ousting RAGE in melanoma: A viable therapeutic target?
   Deeba N. Syed et al, 2017, Seminars in Cancer Biology CrossRef
7. HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets
   Petra Tesarova et al, 2016, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub CrossRef
8. No association between HMGB1 polymorphisms and cancer risk: evidence from a meta-analysis
   Xing-yan Li et al, 2018, Biosci. Rep. CrossRef
9. High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson’s disease
   Aslıhan Baran et al, 2018, Neurol Sci CrossRef
10. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
    Fei Qian et al, 2019, Mol Carcinog CrossRef
11. Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
    Leena Tiainen et al, 2019, Clin Breast Cancer CrossRef
12. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells.
    Hongliang Fang et al, 2014, Cell Mol Immunol CrossRef
13. Hairpin ODN-based ligands as potential inhibitors of HMGB1 cytokine activity
    Domenica Musumeci et al, 2013, RSC Adv. CrossRef
14. HMGB1: A Promising Therapeutic Target for Prostate Cancer
    Munirathinam Gnanasekar et al, 2013, Prostate Cancer CrossRef
15. RAGE and TLRs: Relatives, friends or neighbours?
    Zaridatul Aini Ibrahim et al, 2013, Molecular Immunology CrossRef
16. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.
    Domenica Musumeci et al, 2014, Pharmacol Ther CrossRef
17. HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target
    Madhuwanti Srinivasan et al, 2014, HORM CANC CrossRef
18. Role of high-mobility group box 1 protein in inflammatory bowel disease.
    Zhen Hu et al, 2015, Inflamm Res CrossRef
19. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells
    Kamolporn Amornsupak et al, 2014, BMC Cancer CrossRef
20. Mitochondrial ROS Induces Cardiac Inflammation via a Pathway through mtDNA Damage in a Pneumonia-Related Sepsis Model
    Xiao Yao et al, 2015, PLoS ONE CrossRef
21. HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2.
    Yanmei Chen et al, 2016, Tumour Biol CrossRef
22. Ethyl Pyruvate Administration Suppresses Growth and Invasion of Gallbladder Cancer Cells via Downregulation of Hmgb1-Rage Axis
    M-L. Li et al, 2012, Int J Immunopathol Pharmacol CrossRef
23. High ASMA+ Fibroblasts and Low Cytoplasmic HMGB1+ Breast Cancer Cells Predict Poor Prognosis.
    Kamolporn Amornsupak et al, 2017, Clin Breast Cancer CrossRef
24. HMGB1 is a promising therapeutic target for acute liver failure
    Tetsu Yamamoto et al, 2017, Expert Review of Gastroenterology & Hepatology CrossRef
25. Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer
    Petra Tesarova et al, 2017, Tumour Biol. CrossRef
26. Rs145204276 and rs4759314 affect the prognosis of prostate cancer by modulating the GAS5/miR-1284/HMGB1 and HOTAIR/miR-22/HMGB1 signalling pathways
    Zhi-Hai Deng et al, 2020, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
27. Endoplasmic reticulum stress induces secretion of high-mobility group proteins and is associated with tumor-infiltrating lymphocytes in triple-negative breast cancer
    In Ah Park et al, 2016, Oncotarget CrossRef
28. High mobility group Box-1 inhibits cancer cell motility and metastasis by suppressing activation of transcription factor CREB and nWASP expression
    Zhenghong Zuo et al, 2014, Oncotarget CrossRef
29. RAGE Signaling in Melanoma Tumors
    Olamide T. Olaoba et al, 2020, IJMS CrossRef
30. Controlling cancer-induced inflammation with a nucleic acid scavenger prevents lung metastasis in murine models of breast cancer
    Eda K. Holl et al, 2020, Molecular Therapy CrossRef
31. Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer.
    Sakshi Taneja et al, 2021, Int J Mol Sci CrossRef
32. “Quinolinic Acid Hypothesis” in Chronic Kidney Disease: Elucidation of a Novel Pathological Mechanism for Renal Fibrosis and Creation of Functional Food for Renal Protection
    Ken-Ichi KOBAYASHI, 2020, KAGAKU TO SEIBUTSU CrossRef
33. miR‑340‑5p inhibits pancreatic acinar cell inflammation and apoptosis via targeted inhibition of HMGB1
    Yazhou Gao et al, 2021, Exp Ther Med CrossRef